CURRENT AFFAIRS

Detailed explanation-1: -Abràmoff had long wondered whether a computer program could be used to screen people for eye disease. Over several decades, he developed IDx-DR, an artificial intelligence (AI) system that can tell in minutes whether a person has a more-than-mild case of diabetic retinopathy.

Detailed explanation-2: -Compared with manual work, AI systems are more sensitive and less specific for the diagnosis of DR. Several studies have also shown that AI systems can greatly reduce the workload of manual grading of DR. For example, RetMarker can reduce the workload of manual grading images by 48.42%.

Detailed explanation-3: -The EyeArt system autonomously analyzes patient’s retinal images to robustly detect signs of disease and returns an easy-to-read report in under 60 seconds. The report provides eye level and patient level diabetic retinopathy outputs and also indicates presence or absence of referable DR or vision threatening DR.

Detailed explanation-4: -The artificial intelligence DR screening system helps to provide primary retinal screening for diabetic patients in communities, which could prevent diabetic patients from potential visual threat and help to reduce the DR disease burden.

Detailed explanation-5: -AI is used to spot patterns in behavior that lead to either high or low blood sugar levels in diabetes patients. Continuous glucose monitors used by those with diabetes collect a huge amount of data that has previously not been used efficiently.